Ocular Therapeutix, Inc. (OCUL) vs Vericel Corporation (VCEL)
Ocular Therapeutix, Inc. and Vericel Corporation are both Biotechnology companies. Ocular Therapeutix, Inc. and Vericel Corporation are of similar size ($2.2B and $2.0B). Ocular Therapeutix, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 82.6×. Vericel Corporation grew revenue faster over the last twelve months: 23.0% against −8.14%. Vericel Corporation has the higher net margin (7.91% vs −579.1%) and the higher return on invested capital (5.49% vs 0.00%). Across the 19 metrics below, Vericel Corporation leads on 15 and Ocular Therapeutix, Inc. on 4.
Valuation
Profitability
| Metric | OCUL | VCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.11% | 74.56% | 65.16% |
| Operating margin | (603.04%) | 5.95% | 0.00% |
| Net margin | (579.10%) | 7.91% | 0.00% |
| Free cash flow margin | (490.07%) | 20.13% | 0.00% |
| Return on equity | (72.99%) | 7.16% | (57.72%) |
| Return on assets | (53.70%) | 5.16% | (49.22%) |
| Return on invested capital | 0.00% | 5.49% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack